肥胖与吸烟和血管舒缩更年期症状风险的汇总分析
该研究汇总8项队列研究21,460名中年女性的数据,分析体重指数与吸烟和血管舒缩症状风险的关联。横断面分析显示高体重指数和吸烟与更频繁或严重的症状相关,吸烟加剧肥胖效应,但绝经后女性中体重指数与症状风险呈反向关联。
要点
- 肥胖(BMI≥25 kg/m2)与吸烟呈剂量-反应方式增加频繁或严重血管舒缩症状风险。
- 吸烟加剧肥胖效应,肥胖吸烟者风险比值比为3.02(95%CI 2.41-3.78)。
- 绝经前和围绝经期高BMI增加症状风险,绝经后则降低风险。
核心结论
- 高体重指数(≥25 kg/m2)和吸烟以剂量-反应方式显著增加女性频繁或严重血管舒缩症状风险,吸烟加剧肥胖效应,但体重指数对绝经后女性症状风险影响相反。
研究设计与样本
- 国际生殖健康与慢性病事件生命历程方法协作组汇总8项研究21,460名中年女性(中位年龄50岁,四分位距49-51岁)进行横断面分析,其中4项研究提供前瞻性分析数据(n=11,986)。
主要发现
- 基线时近60%女性经历血管舒缩症状,其中30%超重、21%肥胖、17%当前吸烟。
- 横断面分析显示较高体重指数和吸烟更多、时间更长、开始更早均与更频繁或严重症状相关。
- 从不吸烟的肥胖者相比正常体重从不吸烟者,频繁/严重症状风险比值比为1.52(95%CI 1.35-1.73)。
- 肥胖吸烟者频繁/严重症状风险比值比为3.02(95%CI 2.41-3.78)。
- 前瞻性分析显示类似模式,但调整基线症状后关联明显减弱;体重指数与症状关联因绝经状态而异。
关键数值与推荐
- 从不吸烟肥胖者频繁/严重症状相对风险比1.52(95%CI 1.35-1.73)。
- 肥胖吸烟者频繁/严重症状相对风险比3.02(95%CI 2.41-3.78)。
- 40岁前戒烟者风险水平与从不吸烟者相似。
临床怎么用
- 在绝经过渡前保持正常体重和40岁前戒烟可能减轻中年血管舒缩症状的额外风险。
局限性
- 前瞻性分析中调整基线血管舒缩症状后关联明显减弱。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Frequent and severe vasomotor symptoms during menopause are linked with adverse health outcomes. Understanding modifiable lifestyle factors for the risk of vasomotor menopausal symptoms is important to guide preventive strategies. OBJECTIVE: We investigated the associations between body mass index and smoking, their joint effects with the risk of vasomotor symptoms, and whether the associations differed by menopausal stage. STUDY DESIGN: The International Collaboration for a Life Course Approach to Reproductive Health and Chronic Disease Events pooled data on 21,460 midlife women from 8 studies (median age, 50 years; interquartile range, 49-51 years) for the cross-sectional analysis. Four studies provided data for the prospective analysis (n=11,986). Multinomial logistic regression models with 4 categories of frequency/severity for the outcome of vasomotor symptoms were used to estimate relative risk ratios and 95% confidence intervals that were adjusted for within-study correlation and covariates. RESULTS: At baseline, nearly 60% of the women experienced vasomotor symptoms. One-half of them were overweight (30%) or obese (21%), and 17% were current smokers. Cross-sectional analyses showed that a higher body mass index and smoking more cigarettes with longer duration and earlier initiation were all associated with more frequent or severe vasomotor symptoms. Never smokers who were obese had a 1.5-fold (relative risk ratio, 1.52; 95% confidence interval, 1.35-1.73) higher risk of often/severe vasomotor symptoms, compared with never smokers who were of normal-weight. Smoking strengthened the association because the risk of often/severe vasomotor symptoms was much greater among smokers who were obese (relative risk ratio, 3.02; 95% confidence interval, 2.41-3.78). However, smokers who quit at <40 years of age were at similar levels of risk as never smokers. Prospective analyses showed a similar pattern, but the association attenuated markedly after adjustment for baseline vasomotor symptoms. Furthermore, we found that the association between body mass index and vasomotor symptoms differed by menopausal status. Higher body mass index was associated with increased risk of vasomotor symptoms in pre- and perimenopause but with reduced risk in postmenopause. CONCLUSION: High body mass index (≥25 kg/m2) and cigarette smoking substantially increased women's risk for experiencing frequent or severe vasomotor symptoms in a dose-response manner, and smoking intensified the effect of obesity. However, the effect of body mass index on the risk of vasomotor symptoms was opposite among postmenopausal women. Maintaining a normal weight before the menopausal transition and quitting smoking at <40 years of age may mitigate the excess risk of vasomotor symptoms in midlife.
引用
- Anderson DJ, Chung HF, Seib CA, et al. Obesity, smoking, and risk of vasomotor menopausal symptoms: a pooled analysis of eight cohort studies. Am J Obstet Gynecol. 2019. PMID: 31705884. doi:10.1016/j.ajog.2019.10.103
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。